Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pregna Planta Plus is an herbal-based dietary supplement developed by ORENDA Pharma, specifically formulated to support women during pregnancy. The product is primarily indicated for the management of pregnancy-induced nausea and vomiting, commonly known as morning sickness, and to provide essential nutritional support. Its formulation typically centers on the antiemetic properties of ginger (Zingiber officinale) extract, which contains active compounds like gingerols and shogaols that modulate gastrointestinal motility and serotonin signaling. Additionally, Pregna Planta Plus often includes vitamins such as pyridoxine (Vitamin B6) and folic acid to support metabolic health and fetal neural development. It is marketed as a natural alternative or adjunct to pharmacological treatments for gestational discomforts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pregna Planta Plus.